GSK and Dundee to find new drugs for tropical diseases with Wellcome Trust funding
This article was originally published in Scrip
Executive Summary
The development of new drugs for neglected tropical diseases is the subject of the latest agreement between GlaxoSmithKline and the University of Dundee. The partnership will focus on a series of preclinical compounds for leishmaniasis, Chagas' disease and African sleeping sickness, supported by a grant of £8.6 million from the Wellcome Trust.